$TirzepatidePriceGuide
Medical review

Medical reviewers

Who medically reviews this site, and what a medical review covers.

Released: · Last reviewed:

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 10, 2026 · This page is informational and does not constitute medical advice.

Our reviewers

Dr. Parmis

Medical Researcher · Western University of Health Sciences

Researches every page: first-party price reads, trial attribution and regulatory status.

Dr. Jonathan Snipes, MD

Medical reviewer · NPI 1821250077

Medically reviews every page for clinical accuracy, safety language and FDA status.

Kim Callender, NP (FNP-BC)

Medical reviewer · NPI 1144661760

Medically reviews every page alongside Dr. Snipes.

What a medical review covers

  • Clinical statements, dosing descriptions and side-effect language.
  • Trial results attributed to the right trial and estimand (for example, SURMOUNT-1 15 mg: 20.9% treatment-regimen estimand).
  • FDA status: compounded tirzepatide is not FDA-approved and is not the same product as Zepbound or Mounjaro.
  • Safety warnings, including the boxed warning about thyroid C-cell tumors.

Prices are researched and dated separately; a medical review does not verify a program's price. Each page shows its "Last medically reviewed" date.